Environmental Atherosclerosis Studies
Environmental Atherosclerosis Studies
批准号:
6681847
负责人:
Robert C Sills
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
1 carbon compound apolipoprotein E atherosclerosis atherosclerotic plaque disease /disorder etiology disease /disorder model environmental exposure environmental toxicology gene targeting genetic disorder genetic susceptibility genetically modified animals inhalation drug administration laboratory mouse pathologic process
中文摘要
工作概述:心血管生物学的研究人员正在努力确定参与动脉粥样硬化各个阶段的重要细胞和分子,以及促进病变形成的环境和遗传因素。模仿人类疾病的体内模型或过于依赖体外系统可能会产生误导。直到最近,动脉粥样硬化的研究主要集中在灵长类动物和低密度脂蛋白(LDL)受体缺乏的兔子身上。采用吸入法研究C57BL/6小鼠二硫化碳动脉粥样硬化的进展及机制;一个更适合外推到人类身上的模型。新的研究将集中在使用ApoE敲除小鼠来解决环境暴露后动脉粥样硬化假说。
英文摘要
Summary of Work: Researchers in cardiovascular biology are working to identify the important cells and molecules involved in each stage of atherosclerosis, as well as the environmental and genetic factors that promote lesion formation. In vivo models that mimic the human disease or rely too heavily on in vitro systems could be misleading. Until recently, atherogenesis had been studied mainly in primates and in low density lipoprotein (LDL) receptor deficient rabbits. An inhalation study was conducted to investigate the progression and mechanism of carbon disulfide atherosclerosis in C57BL/6 mice; a model more appropriate for extrapolation to humans. New studies will focus on the use of ApoE knock out mice to address atherosclerosis hypothesis following environmental exposure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MRM OF BRAIN LESIONS FOLLOWING CARBONYL SULFIDE EXPOSURE
-
批准号:7358301
-
项目类别:
-
资助金额:$0.51万
-
财政年份:2006
-
负责人:Robert C Sills
-
依托单位:
MRM OF BRAIN LESIONS FOLLOWING CARBONYL SULFIDE EXPOSURE
-
批准号:7181582
-
项目类别:
-
资助金额:$0.53万
-
财政年份:2005
-
负责人:Robert C Sills
-
依托单位:
INHALATION TOXICITY OF VOLATILE ORGANIC CHEMICALS--CARBON DISULFIDE
-
批准号:6289900
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
CARBONYL SULFIDE CLEAN AIR ACT STUDIES
-
批准号:6289915
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
Carbonyl Sulfide and Carbon Disulfide Clean Air Act Neur
-
批准号:6837409
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
Carbonyl Sulfide and Carbon Disulfide Clean Air Act Neur
-
批准号:7161823
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
Genetic Alterations In Rodent Cancer
-
批准号:7734408
-
项目类别:
-
资助金额:$135.36万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
Clean Air Act Neurotoxicity Studies and NTP/NIEHS Neuropathology Evaluations
-
批准号:7734409
-
项目类别:
-
资助金额:$24.36万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
Carbonyl Sulfide Clean Air Act Studies
-
批准号:6675544
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
Molecular Evaluation Of Cobalt Sulfate Lung Neoplasms
-
批准号:6677448
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
RELEVANCE OF CHEMICALLY INDUCED FORESTOMACH NEOPLASMS IN B6C3F1 MOUSE
-
批准号:6106607
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
Environmental Atherosclerosis Studies
-
批准号:7006540
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
ENVIRONMENTAL ATHEROSCLEROSIS STUDIES
-
批准号:6289913
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
ENVIRONMENTAL ATHEROSCLEROSIS STUDIES
-
批准号:6432255
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
MOLECULAR EVALUATION OF 2,2-Bis(bromomethyl)-1,3-Propanediol(BMP) B6C3F1 Mouse
-
批准号:6432259
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
INHALATION TOXICITY OF VOLATILE ORGANIC CHEMICALS--CARBON DISULFIDE
-
批准号:6432241
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
CARBONYL SULFIDE CLEAN AIR ACT STUDIES
-
批准号:6432257
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
Environmental Atherosclerosis Studies
-
批准号:6540984
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
Inhalation Toxicity Of Volatile Organic Chemicals--carbo
-
批准号:6540977
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
Inhalation Toxicity Of Volatile Organic Chemicals--carbo
-
批准号:6681842
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Robert C Sills
-
依托单位:
海外基金